(Q39757608)

14 September 2017

title

Metastatic colorectal cancer KRAS genotyping in routine practice: results and pitfalls (English)

1 reference

14 September 2017

1 reference

metastatic colon cancer

1 reference

1 reference

Aude Lamy

1

1 reference

14 September 2017

France Blanchard

2

1 reference

14 September 2017

Florence Le Pessot

3

1 reference

14 September 2017

Richard Sesboüé

4

1 reference

14 September 2017

Frédéric Di Fiore

5

1 reference

14 September 2017

Jessie Bossut

6

1 reference

14 September 2017

Elodie Fiant

7

1 reference

14 September 2017

Thierry Frébourg

8

1 reference

14 September 2017

Jean-Christophe Sabourin

9

1 reference

14 September 2017

publication date

22 April 2011

1 reference

14 September 2017

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

1090-1100

1 reference

Untangling the ErbB signalling network

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Guilty as charged: B-RAF is a human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

21 January 2018

Assessing EGFR mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

A high frequency of sequence alterations is due to formalin fixation of archival specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

RAF/RAS oncogenes and mismatch-repair status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

DNA sequences from multiple amplifications reveal artifacts induced by cytosine deamination in ancient DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

KRAS genotyping of paraffin-embedded colorectal cancer tissue in routine diagnostics: comparison of methods and impact of histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Evolution of intratumoral genetic heterogeneity during colorectal cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Patterns of nucleotide misincorporations during enzymatic amplification and direct large-scale sequencing of ancient DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Instability and decay of the primary structure of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Feasibility of archival non-buffered formalin-fixed and paraffin-embedded tissues for PCR amplification: an analysis of resected gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

Moyamoya disease and moyamoya syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

7 January 2021

A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urine

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

7 January 2021

Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

7 January 2021

Prevalence and heterogeneity of KRAS, BRAF, and PIK3CA mutations in primary colorectal adenocarcinomas and their corresponding metastases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2011.60

7 January 2021

10.1038/MODPATHOL.2011.60

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

1045570236

0 references

1 reference